U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 130.100 Inspectional Authority; Refusal to Permit Inspection.
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 130.100 Inspectional Authority; Refusal to Permit Inspection. October 1980

Final

BACKGROUND:

The authority for duly appointed officers or employees of the Food and Drug Administration to enter and inspect establishments under the jurisdiction of the Federal Food, Drug, and Cosmetic Act is in Section 704 of the Act (21 U.S.C. 374).

Questions concerning the right to inspect such establishments have often been raised and litigated. The courts have upheld the legality of an FDA inspection if it is conducted at a reasonable time, within reasonable limits and in a reasonable manner*. Consent is not the basis upon which a Food and Drug inspection is conducted, and permission or authorization to inspect is not required from the firm to be inspected.

The Federal Food, Drug, and Cosmetic Act provides criminal penalties for refusal to permit a lawful inspection.

POLICY:

The legality of an FDA inspection, conducted at a reasonable time, and within reasonable limits, and in a reasonable manner, depends not on consent but on the validity of statutory authority. An inspection warrant is not a prerequisite to lawful inspection pursuant to such authority. Refusal to permit inspection, upon presentation of official notice by appropriately identified Food and Drug Administration officers or employees pursuant to 21 U.S.C. 374, exposes any person responsible for such refusal to criminal penalties under 21 U.S.C. 331(f) and 333.

*United States v. Biswell, 92 S. Ct. 1593 (1972)

United States v. Del Campo Baking Mfg. Company, 345 F. Supp. 1371 (D., Del., 1972)

United States v. Business Builders, Inc., 353 F. Supp. 1333 (N.D. Okla., 1973)

Issued: 10/1/80

Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

 
Back to Top